The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Because monoclonal antibodies (mAbs) directed against alpha4-integrin and VCAM-1 inhibit the development of experimental autoimmune encephalomyelitis (EAE) in vivo, it has been concluded that the successful therapeutic effect is due to interference with alpha4beta1/VCAM-1-mediated interaction of autoaggressive T cells with the blood-brain barrier. A possible role for alpha4beta7-integrin, or interference with other T cell mediated events during the pathogenesis of EAE, has not been considered. We have compared the effects of mAb therapy on the development of EAE in the SJL/N mouse, using a large panel of mAbs directed against alpha4, beta7, the alpha4beta7-heterodimer, and against VCAM-1. Although encephalitogenic T cells express both alpha4-integrins, mAbs directed against the alpha4beta7-heterodimer or against the beta7-subunit did not interfere with the development of EAE. In contrast, mAbs directed against alpha4 and VCAM-1 inhibited or diminished clinical or histopathological signs of EAE. Our data demonstrate for the first time that alpha4beta7 is not essential for the development of EAE. Furthermore, our in vitro studies suggest that the therapeutic effect of anti-alpha4-treatment of EAE might also be caused by inhibition of antigen-specific T cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a neutralizing antibody against α4-integrin, which pairs with β1-integrin to form very late antigen-4 (VLA-4), which mediates leukocyte adhesion to the inflamed endothelium via VCAM-1 (22), did not reduce LPS-induced vascular leakage (SI Appendix, Fig. S12).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929 · cited 1×
“on the surface of leukocytes and endothelial cells are actively involved in the recruitment of specific leukocyte subsets into different tissues (1, 2).”
BackgroundLeukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
Butcher, E. C. (1991) · Cell · doi:10.1016/0092-8674(91)90279-8 · Cited by 2,761 · cited 1×
“on the surface of leukocytes and endothelial cells are actively involved in the recruitment of specific leukocyte subsets into different tissues (1, 2).”
BackgroundPrevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835 · cited 6×
“2, although a poor inhibitor of a 4-integrin–mediated lymphocyte homing in vivo (18), has been shown to interfere with the development of EAE (17).”
BackgroundMethodResultInfluentialStamper, H. B., & Woodruff, J. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.3.828 · Cited by 670 · cited 1×
“Evidence for the functional importance of cerebral endothelial expression of ICAM-1 and VCAM-1 is provided by studies using a modified Stamper-Woodruff frozen section assay (10).”
MethodRole of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo.
Hamann, A., Andrew, D. P., Jablonski-Westrich, D., Holzmann, B., & Butcher, E. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3282 · Cited by 628 · cited 3×
“However, the very same mAbs have been demonstrated to successfully inhibit a4b7mediated lymphocyte homing into mucosal lymph nodes in healthy animals (18) and to inhibit spontaneous autoimmune diabetes (31).”
BackgroundEvidence for a role of the integrin VLA-4 in lympho-hemopoiesis.
Miyake, K., Weissman, I. L., Greenberger, J. S., & Kincade, P. W. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.599 · Cited by 589
Holzmann, B., McIntyre, B. W., & Weissman, I. L. (1989) · Cell · doi:10.1016/0092-8674(89)90981-1 · Cited by 479
Jalkanen, S. T., Bargatze, R. F., Herron, L. R., & Butcher, E. C. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161003 · Cited by 416
Miyake, K., Medina, K., Ishihara, K., Kimoto, M., Auerbach, R., & Kincade, P. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.3.557 · Cited by 381
Cited by
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 778
“Intravital microscopy studies of brain meningeal vessels and of the spinal cord microvasculature of mice suffering from EAE have shown that blocking α4-integrin [71] or lack of β1-integrin [72] on myelin-specific T cells does not allow them to maintain stable adhesions with the CNS microvascular endothelium and thus p…”
BackgroundSelf-citationCapture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686
Self-citationThe ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms
Engelhardt, B., & Ransohoff, R. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.07.004 · Cited by 673
Self-citationSixt, M., Engelhardt, B., Pausch, F., Hallmann, R., Wendler, O., & Sorokin, L. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.933 · Cited by 507
“Protein–lipid–protein (PLP)-specific T cell lines were established as described in detail previously (Engelhardt et al., 1997, 1998).”
BackgroundMethodSelf-citationSoler, D., Chapman, T., Yang, L.-L., Wyant, T., Egan, R., & Fedyk, E. R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.153973 · Cited by 456
“…of IBD, and the molecular mechanisms by which these lymphocytes enter the gut are distinct from those in other peripheral tissues, such as the skin and central nervous system (Butcher and Picker, 1996; Engelhardt et al., 1998; Engelhardt and Briskin, 2005; Salmi and Jalkanen, 2005; Agace, 2006).”
BackgroundWolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454
“Active EAE (aEAE) was induced by immunization with syngeneic spinal cord homogenate as described in detail before [4, 5].”
MethodSelf-citationLiesz, A., Zhou, W., Mracskó, É., Karcher, S., Bauer, H., Schwarting, S., Sun, L., Bruder, D., Stegemann, S., Cerwenka, A., et al. (2011) · Brain · doi:10.1093/brain/awr008 · Cited by 411
Vajkoczy, P., Laschinger, M., & Engelhardt, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12440 · Cited by 357
“Evidence for an involvement of α4-integrin in antigen-specific T cell proliferation (2) or maintaining the residency of inflammatory cells within the CNS parenchyma during EAE (10) has been provided.”
BackgroundMethodResultInfluentialSelf-citationAn inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium
Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D., & Jackson, D. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051759 · Cited by 346
Molecular mechanisms involved in T cell migration across the blood–brain barrier
Engelhardt, B. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0409-y · Cited by 343
“…of traffic signals like adhesion molecules and chemokines, leads to enhanced leukocyte traffic into the CNS and consecutively chronic inflammation, however T lymphocyte entry is limited to T cells with an activated=memory and a characteristic adhesion molecule phenotype (Engelhardt et al., 1998b).”
BackgroundSelf-citationFactors controlling permeability of the blood–brain barrier
Almutairi, M. M. A., Gong, C., Xu, Y. G., Chang, Y., & Shi, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 306
Anti-α4 integrin therapy for multiple sclerosis: Mechanisms and rationale
Rice, G. P. A., Hartung, H.-P., & Calabresi, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000158329.30470.d0 · Cited by 305
Marchetti, L., & Engelhardt, B. (2020) · Vascular Biology · doi:10.1530/vb-19-0033 · Cited by 304
“EAE studies have ruled out the involvement of integrin α 4 β 7 in T-cell arrest on the BBB (79, 80, 81), while recent evidence has suggested a specific role for α v β 3 integrin in Th17 cell-mediated EAE pathology in mice (82).”
BackgroundSelf-citationAdhesion molecule expression and regulation on cells of the central nervous system
Lee, S. J., & Benveniste, E. N. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00084-3 · Cited by 296
Steiner, O., Coisne, C., Cecchelli, R., Boscacci, R., Deutsch, U., Engelhardt, B., & Lyck, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903732 · Cited by 293
“For all experiments, we used a murine PLP-specific CD4 Th1 effector/memory T cell line that has been well characterized for its high predisposition to interact with the BBB; in vivo, these T cells migrate across the BBB and induce experimental autoimmune encephalomyelitis (EAE) when injected into susceptible mouse str…”
MethodSelf-citationMitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.008 · Cited by 283
“The effect of α4 antibodies was mediated by blockade of α4β1- rather than α4β7-integrin, as clarified by inhibition studies with antibodies against α4β7 heterodimer or β7-integrin (Engelhardt et al., 1998), whereas endothelial overexpression of the α4β7-integrin counterreceptor MAdCAM-1 did not affect EAE severity (Dö…”
Backgroundα4Integrins as Therapeutic Targets in Autoimmune Disease
von Andrian, U. H., & Engelhardt, B. (2003) · New England Journal of Medicine · doi:10.1056/nejme020157 · Cited by 276
Self-citationGraesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., & Madri, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213595 · Cited by 273
“The derivation and maintenance of the proteolipid protein–specific (PLP-specific) T cell lines were described in detail previously (42, 43).”
BackgroundSelf-citationFloris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
“…either by direct blocking adhesion molecule interaction (Yednock et al., 1992; Baron et al., 1993; Huitinga et al., 1993; Gordon et al., 1995; Engelhardt et al., 1998; Brocke et al., 1999; Miller et al., 2003) or by diminishing cellular diapedesis by immunomodulation as has been shown for…”
BackgroundEngelhardt, B., & Coisne, C. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-4 · Cited by 246
“The development of EAE can be abrogated by blocking a4-integrins or VCAM-1 as shown by many laboratories [54,60,66-68].”
Self-citationImproving Outcome after Stroke: Overcoming the Translational Roadblock
Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., Planas, A., Rothwell, N., Schwaninger, M., Schwab, M. E., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000118039 · Cited by 258
“In order to understand which leucocyte subpopulations confer beneficial rather than detrimental effects, it is mandatory to understand first the multi-step recruitment cascade of leucocyte subpopulations across the BBB [31] . To date, these processes have been investigated mostly during auto-immune CNS inflammation […”
BackgroundSelf-citationRaivich, G., & Banati, R. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.06.006 · Cited by 248
Wolburg, H., Wolburg-Buchholz, K., & Engelhardt, B. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0928-x · Cited by 225
Self-citationCalzascia, T., Masson, F., Di Berardino-Besson, W., Contassot, E., Wilmotte, R., Aurrand-Lions, M., Rüegg, C., Dietrich, P.-Y., & Walker, P. R. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.008 · Cited by 235
Wimmer, I., Tietz, S., Nishihara, H., Deutsch, U., Sallusto, F., Gosselet, F., Lyck, R., Muller, W. A., Lassmann, H., & Engelhardt, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00711 · Cited by 233
“PLP7 were used 2–3 days after the 3rd, 4th, 5th, or 7th restimulation with their specific PLP peptide aa139-151 (58).”
MethodSelf-citationEnzmann, G., Mysiorek, C., Gorina, R., Cheng, Y.-J., Ghavampour, S., Hannocks, M.-J., Prinz, V., Dirnagl, U., Endres, M., Prinz, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1076-3 · Cited by 225
Self-citationAlt, C., Laschinger, M., & Engelhardt, B. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2133::aid-immu2133>3.0.co;2-w · Cited by 248
Self-citationKerfoot, S. M., & Kubes, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1000 · Cited by 210
Wolburg, H., Wolburg-Buchholz, K., Liebner, S., & Engelhardt, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01927-9 · Cited by 210
Self-citationvan Loo, G., De Lorenzi, R., Schmidt, H., Huth, M., Mildner, A., Schmidt-Supprian, M., Lassmann, H., Prinz, M. R., & Pasparakis, M. (2006) · Nature Immunology · doi:10.1038/ni1372 · Cited by 197
“VCAM-1 is considered to be the main adhesion molecule involved in the trafficking of leukocytes across the blood-brain barrie”
BackgroundIfergan, I., Kebir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R., Arbour, N., & Prat, A. (2008) · Brain · doi:10.1093/brain/awm295 · Cited by 196
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Thomas, S., & Baumgart, D. C. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0104-6 · Cited by 191
Coisne, C., Dehouck, L., Faveeuw, C., Delplace, Y., Miller, F., Landry, C., Morissette, C., Fenart, L., Cecchelli, R., Tremblay, P., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700281 · Cited by 183
Zhu, X., Nishimura, F., Sasaki, K., Fujita, M., Dusak, J. E., Eguchi, J., Fellows-Mayle, W., Storkus, W. J., Walker, P. R., Salazar, A. M., et al. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-10 · Cited by 194
“VLA-4 allows activated T-cells to adhere to vascular celladhesion molecule (VCAM)-1+ endothelial cells [17,18].”
BackgroundT‐cell trafficking in the central nervous system
Sallusto, F., Impellizzieri, D., Basso, C., Laroni, A., Uccelli, A., Lanzavecchia, A., & Engelhardt, B. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01140.x · Cited by 186
“with the BBB during EAE was provided by experiments showing that antibodies blocking a4b7 or b7 failed to have any impact on EAE development in SJL mice (63) and that b1-”
MethodSelf-citationGorina, R., Lyck, R., Vestweber, D., & Engelhardt, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300858 · Cited by 182
“2) have been described in great detail previously (40).”
BackgroundSelf-citationImmune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines
Engelhardt, B. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.019 · Cited by 180
“In fact, as we and the others have previously demonstrated that α4-integrins are involved in T cell activation [6,21] some other α4-integrin-dependent pathomechanisms, entirely independent of leukocyte trafficking, may contribute to the therapeutic success of targeting α4-integrins in EAE.”
Self-citationCentral Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis
Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A., & Coffman, R. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.602 · Cited by 182
Interferon-β directly influences monocyte infiltration into the central nervous system
Floris, S., Ruuls, S. R., Wierinckx, A., van der Pol, S. M. A., Döpp, E., van der Meide, P. H., Dijkstra, C. D., & De Vries, H. E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00098-x · Cited by 179
“…(mAb) directed against adhesion molecules like ICAM-1, VCAM-1 and their counterligands influenced clinical signs and the formation of cellular infiltrates during EAE (Brocke et al., 1999; Engelhardt et al., 1998; Yednock et al., 1992; Baron et al., 1993; Huitinga et al., 1993; Gordon et al., 1995).”
BackgroundInvolvement of the choroid plexus in central nervous system inflammation
Engelhardt, B., Wolburg-Buchholz, K., & Wolburg, H. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010101)52:1<112::aid-jemt13>3.0.co;2-5 · Cited by 177
“Even during inflammation, when the endothelial BBB becomes leaky, lymphocyte recruitment into the CNS seems to be tightly controlled as T cells detected in the CNS parenchyme are phenotypically distinct from T cell populations detected in other inflamed organs (Engelhardt et al., 1995, 1998b).”
BackgroundSelf-citationDysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
“For migration of T-cells across the endothelial cell monolayer, 1 10(5) proteolipid protein (PLP)-specific, freshly restimulated T-helper 1 memory/effector T-cells (SJLB/PLP4) (34, 35) were added on top of unstimulated bEnd5 cells in 100 KL MAM.”
MethodSelf-citationNatalizumab: Targeting α4-Integrins in Multiple Sclerosis
Engelhardt, B., & Kappos, L. (2008) · Neurodegenerative Diseases · doi:10.1159/000109933 · Cited by 154
Self-citationA randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B. L., Schreiber, S., Mansfield, J. C., Williams, M. B., Tang, M. T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301769 · Cited by 152
Laschinger, M., & Engelhardt, B. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00156-3 · Cited by 149
“Recently we could show that several antibodies directed against a4-integrin and also a panel of antibodies directed against endothelial VCAM-1 successfully inhibited the development of clinical EAE whereas antibodies directed against b7-integrin or against the a4b7-heterodimer did not interfere with the disease course…”
InfluentialSelf-citationLyck, R., Reiss, Y., Gerwin, N., Greenwood, J., Adamson, P., & Engelhardt, B. (2003) · Blood · doi:10.1182/blood-2003-02-0358 · Cited by 142
Self-citationTWEAK stimulation of astrocytes and the proinflammatory consequences
Saas, P., Boucraut, J., Walker, P. R., Quiquerez, A., Billot, M., Desplat‐Jégo, S., Chicheportiche, Y., & Dietrich, P. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<102::aid-glia100>3.0.co;2-u · Cited by 134
“To date, most in vitro and in vivo studies have focused on EC, underscoring the role of ICAM-1 and VCAM-1 in leukocyte adhesion and transendothelial migration (Engelhardt et al., 1998; Reiss et al., 1998; Constantin et al., 1999).”
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Martinꝉ, R., Sospedra, M., Rosito, M., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646485 · Cited by 149
Self-citationWegner, C., Stadelmann, C., Pförtner, R., Raymond, E., Feigelson, S., Alon, R., Timan, B., Hayardeny, L., & Brück, W. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.009 · Cited by 120
“This chemokine is thought to strengthen VLA-4-mediated T cell adhesion and migration into the inflamed CNS (Engelhardt et al., 1998; Vajkoczy et al., 2001).”
BackgroundTeijeira, A., Hunter, M. C., Russo, E., Proulx, S. T., Frei, T., Debes, G. F., Coles, M., Melero, I., Detmar, M., Rouzaut, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.078 · Cited by 113
“4; BioLegend), anti-mouse LFA-1 antibody (clone M17/4; BioXCell), anti-mouse VCAM-1 (6C7.1; Engelhardt et al., 1998), or corresponding isotypes (from BioLegend or BioXCell), in 10 mL were co-injected into the dorsal half of CHS-inflamed ears of WT mice.”
BackgroundMethodInfluentialDöring, A., Wild, M., Vestweber, D., Deutsch, U., & Engelhardt, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8470 · Cited by 110
Self-citationDuc, D., Vigne, S., Bernier‐Latmani, J., Yersin, Y., Ruiz, F., Gaïa, N., Léo, S., Lazarević, V., Schrenzel, J., Petrova, T. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.002 · Cited by 113
“Using the SJL/N mouse strain, Engelhardt and colleagues found no effect of anti-a4b7- or anti-b7-neutralizing antibodies on the development of EAE (Engelhardt et al., 1998).”
Bauer, M., Brakebusch, C., Coisne, C., Sixt, M., Wekerle, H., Engelhardt, B., & Fässler, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808909106 · Cited by 107
Self-citationSchulz, M., & Engelhardt, B. (2005) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-2-8 · Cited by 94
“It has been shown that endothelial VCAM-1 and ICAM-1 are involved in lymphocyte recruitment across brain endothelium in vitro and in vivo [13,23-25].”
BackgroundMethodSelf-citationDifferential RET Signaling Pathways Drive Development of the Enteric Lymphoid and Nervous Systems
Patel, A., Harker, N., Moreira-Santos, L., Ferreira, M., Alden, K., Timmis, J., Foster, K., Garefalaki, A., Pachnis, P., Andrews, P., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002734 · Cited by 94
Regulation of Immune Cell Entry into the Central Nervous System
Engelhardt, B. (2006) · Springer eBooks · doi:10.1007/400_020 · Cited by 111
Self-citationTargeting β1-integrin inhibits vascular leakage in endotoxemia
Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722317115 · Cited by 95
“Furthermore, a neutralizing antibody against α4-integrin, which pairs with β1-integrin to form very late antigen-4 (VLA-4), which mediates leukocyte adhesion to the inflamed endothelium via VCAM-1 (22), did not reduce LPSinduced vascular leakage (SI Appendix, Fig.”
BackgroundSteiner, O., Coisne, C., Engelhardt, B., & Lyck, R. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.96 · Cited by 94
“PLP7 raised against the PLP peptide aa 139 to 151 has previously been described in detail (”
BackgroundSelf-citationJahromi, N. H., Marchetti, L., Moalli, F., Duc, D., Basso, C., Tardent, H., Kaba, E., Deutsch, U., Pot, C., Sallusto, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03056 · Cited by 102
“Rat-anti-mouse endoglin antibody (clone MJ7/18) (26) was purified endotoxin-free from hybridoma culture supernatants as previously described (27).”
MethodSelf-citationβ7 integrins contribute to demyelinating disease of the central nervous system
Kanwar, J. R., Harrison, J. E. B., Wang, D., Leung, E. Y., Müller, W., Wagner, N., & Krissansen, G. W. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00245-3 · Cited by 93
Kerfoot, S. M., Norman, M. U., Lapointe, B. M., Bonder, C. S., Zbytnuik, L., & Kubes, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6225 · Cited by 88
Minten, C., Alt, C., Gentner, M., Frei, E., Deutsch, U., Lyck, R., Schaeren-Wiemers, N., Rot, A., & Engelhardt, B. (2014) · Brain · doi:10.1093/brain/awu045 · Cited by 87
“In vitro antigen-recall assays to test for antigen-specific proliferation of T cells was determined by measuring 3H-thymidine incorporation into the DNA of proliferating T cells as previously described (Engelhardt et al., 1998; Doring et al., 2007).”
MethodSelf-citationGut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease
Lamb, C. A., O’Byrne, S., Keir, M. E., & Butcher, E. C. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy060 · Cited by 96
Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors
Mrass, P., & Weninger, W. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00433.x · Cited by 104
“VCAM-1 blockade also delayed the onset of EAE, but it had less effect on disease severity or duration (93).”
BackgroundResultHaanstra, K. G., Hofman, S., Estêvão, D. M. L., Blezer, E. L. A., Bauer, J., Yang, L.-L., Wyant, T. L., Csizmadia, V., Hart, B. A. ‘., & Fedyk, E. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202490 · Cited by 87
“In contrast, blocking the a4b1 and a4b7 integrins or VCAM-1 inhibited clinical and histopathological signs of EAE (9).”
BackgroundStroke affects intestinal immune cell trafficking to the central nervous system
Brea, D., Poon, C., Benakis, C., Lubitz, G. S., Murphy, M., Iadecola, C., & Anrather, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.008 · Cited by 91
Engelhardt, B. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2010.009.x · Cited by 78
“However, neutralizing a4b7-integrin antibodies failed to interfere with the development of EAE in SJL mice.(72) Furthermore, b1-integrin deficient myelin-specific T cells fail to firmly adhere to inflamed spinal cord microvessels of mice with EAE,(55) showing that a4b7-integrin cannot compensate for a4b1-integrin in m…”
BackgroundSelf-citationCutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 Cells
Glatigny, S., Duhen, R., Oukka, M., & Bettelli, E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102515 · Cited by 82
How T cells trigger the dissociation of the endothelial receptor phosphatase VE-PTP from VE-cadherin
Vockel, M., & Vestweber, D. (2013) · Blood · doi:10.1182/blood-2013-04-499228 · Cited by 79
Self-citationStefanich, E., Danilenko, D. M., Wang, H., O’Byrne, S., Erickson, R., Gelzleichter, T. R., Hiraragi, H., Chiu, H., Ivelja, S., Jeet, S., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01205.x · Cited by 82
“…T cells, antibodies against a4 (PS/2) inhibited or diminished clinical and histopathological signs of EAE while antibodies against b7 (FIB504 and FIB30) or a4b7 (DATK-32) had no effect, although encephalitogenic T cells expressed both a4b1 and a4b7 integrins (Engelhardt et al., 1998).”
BackgroundLaschinger, M., Vajkoczy, P., & Engelhardt, B. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200212)32:12<3598::aid-immu3598>3.0.co;2-6 · Cited by 82
Self-citationThe role of T cells in the pathogenesis of Parkinson’s disease
Chen, Z., Chen, S., & Liu, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.08.002 · Cited by 86
Distribution of activated T cells migrating through the body: a matter of life and death
Westermann, J., & Bode, U. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01474-7 · Cited by 81
Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
Parikh, A., Fox, I. H., Leach, T. S., Xu, J., Scholz, C. R., Patella, M., & Feagan, B. G. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f538 · Cited by 80
Brakebusch, C., Fillatreau, S., Potocnik, A. J., Bungartz, G., Wilhelm, P., Svensson, M., Kearney, P., Körner, H., Gray, D., & Fässler, R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00281-9 · Cited by 79
Role of the extracellular matrix in lymphocyte migration
Korpos, É., Wu, C., Song, J., Hallmann, R., & Sorokin, L. M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0853-3 · Cited by 84
“…2002) or the lack of β1-integrin (Bauer et al. 2009) on myelin-specific T cells does not allow them to maintain stable adhesions with the CNS microvascular endothelium and thus prohibits their migration across the BBB, resulting in the inhibition of EAE (Bauer et al. 2009; Engelhardt et al. 1998).”
BackgroundDifferential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization
Siffrin, V., Brandt, A. U., Radbruch, H., Herz, J., Boldakowa, N., Leuenberger, T., Werr, J., Hahner, A., Schulze-Topphoff, U., Nitsch, R., et al. (2009) · Brain · doi:10.1093/brain/awn354 · Cited by 75
“The adhesion mol- ecule VLA-4 plays a crucial role in the transmigration process, as interference with a4-integrin binding reduced T-cell entry into the CNS (Engelhardt et al., 1998; Brocke et al., 1999).”
BackgroundMethodInfluentialCastro Dias, M., Odriozola Quesada, A., Soldati, S., Bösch, F., Gruber, I., Hildbrand, T., Sönmez, D., Khire, T., Witz, G., McGrath, J. L., et al. (2021) · Journal of Cell Science · doi:10.1242/jcs.253880 · Cited by 75
“For the in vitro live-cell imaging experiments on pMBMECmonolayers, we used the encephalitogenic CD4+ TEM effector-memory proteolipid protein (PLP) peptide amino acids 139–153-specific T-cell line SJL.PLP7 (CD4+ TEM cells; Engelhardt et al., 1998), as described previously (Abadier et al., 2015; Steiner et al., 2010),…”
BackgroundSelf-citationLyck, R., Lécuyer, M.-A., Abadier, M., Wyss, C. B., Matti, C., Rosito, M., Enzmann, G., Zeis, T., Michel, L., García Martín, A. B., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16678639 · Cited by 75
“To specifically target the role of endothelial ALCAM, we took advantage of the ALCAM / C57BL/6 mouse as a source of pMBMECs.(23,42) ALCAM and CD6 protein expression on mouse encephalitogenic Th1 cells(5,34) was confirmed by flow cytometry (Supplementary Figure 5).”
BackgroundSelf-citationEngelhardt, B., Kempe, B., Merfeld-Clauss, S., Laschinger, M., Furie, B., Wild, M. K., & Vestweber, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1267 · Cited by 73
Self-citationFactors modifying the migration of lymphocytes across the blood–brain barrier
Brown, K. A. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00129-1 · Cited by 75
Gangaraju, R., Willuweit, A., Patterson, C. E., Sun, P., Hilbig, A., Breier, G., Helisch, A., & Clauss, M. A. (2006) · Journal of Vascular Research · doi:10.1159/000090949 · Cited by 74
Migration of T Cells in Vivo: Molecular Mechanisms and Clinical Implications
Westermann, J., Engelhardt, B., & Hoffmann, J. C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-4-200108210-00013 · Cited by 75
Self-citationArasa, J., Collado‐Díaz, V., Kritikos, I., Medina-Sanchez, J. D., Friess, M. C., Sigmund, E. C., Schineis, P., Hunter, M. C., Tacconi, C., Paterson, N., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201413 · Cited by 77
Coisne, C., Lyck, R., & Engelhardt, B. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-7 · Cited by 69
“PLP7, that has been described in detail before [13].”
BackgroundSelf-citationMikulowska-Mennis, A., Xu, B., Berberian, J. M., & Michie, S. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61738-5 · Cited by 77
Wang, J., Qi, Y., Niu, X., Tang, H., Meydani, S. N., & Wu, D. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.004 · Cited by 73
Pharmacological characterization of PF‐00547659, an anti‐human MAdCAM monoclonal antibody
Pullen, N., Molloy, E. J., Carter, D., Syntin, P., Clemo, F. A. S., Finco‐Kent, D., Reagan, W. J., Zhao, S., Kawabata, T. T., & Sreckovic, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00137.x · Cited by 71
“As a4b1/vascular cell adhesion molecule (VCAM)-dependent processes appear to predominate in the recruitment of leukocytes for immune surveillance of the central nervous system (CNS) (Engelhardt et al., 1998; Engelhardt, 2006), the possibility that the blockade of the a4b1 processes directly contributes to the increase…”
BackgroundInfluentialThang, N. N. T., Derouazi, M., Philippin, G., Arcidiaco, S., Berardino-Besson, W. D., Masson, F., Hoepner, S., Riccadonna, C., Burkhardt, K., Guha, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3074 · Cited by 73
O’Sullivan, J. B., Ryan, K. M., Harkin, A., & Connor, T. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.12.007 · Cited by 67
“Targeting the VLA-4–VCAM-1 interaction has also been shown to prevent induction and progression of EAE in preclinical models of MS (Engelhardt et al., 1998; Yednock et al., 1992).”
β1 integrins: zip codes and signaling relay for blood cells
Sixt, M., Bauer, M., Lämmermann, T., & Fässler, R. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.007 · Cited by 64
Martin‐Blondel, G., Pignolet, B., Tietz, S., Yshii, L., Gebauer, C., Perinat, T., Van Weddingen, I., Blatti, C., Engelhardt, B., & Liblau, R. (2015) · European Journal of Immunology · doi:10.1002/eji.201545632 · Cited by 58
“These results strongly suggest that the α4β1-integrin is the essential heterodimer for the interaction of activated CD8 T cells with the BBB. Similarly, blocking α4-integrin can abrogate the development of EAE mediated by encephalitogenic CD4 Th1 cells [7] [8] [9] [10] .”
BackgroundMethodSelf-citationAstrocytes in the tempest of multiple sclerosis
Miljković, D., Timotijević, G., & Stojković, M. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.047 · Cited by 60
“Additionally, it has been shown in EAE in mice that it is a4b1 integrin and not a4b7 integrin that is crucial for the entry of immune cells into the CNS [31,32].”
BackgroundThe central nervous system is a target of acute graft versus host disease in mice
Hartrampf, S., Dudakov, J. A., Johnson, L. K., Smith, O. M., Tsai, J. J.-Y., Singer, N. V., West, M. L., Hanash, A. M., Albert, M. H., Liu, B., et al. (2013) · Blood · doi:10.1182/blood-2012-09-456590 · Cited by 59
Reversible retinal vessel closure from VEGF-induced leukocyte plugging
Liu, Y., Shen, J., Fortmann, S. D., Wang, J., Vestweber, D., & Campochiaro, P. A. (2017) · JCI Insight · doi:10.1172/jci.insight.95530 · Cited by 59
“1) (64, 65) overnight at 4°C followed by incubation in goat anti-rat secondary antibody conjugated with Alexa Fluor 594 and Hoechst (Sigma-Aldrich).”
MethodSelf-citationLeone, D. R., Giza, K., Gill, A., Dolinski, B. M., Yang, W. J., Perper, S. J., Scott, D. M., Lee, W.-C., Cornebise, M., Wortham, K. A., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047332 · Cited by 59
“Conversely, Englehardt et al. (Engelhardt et al., 1995, 1998; Laschinger and Engelhardt, 2000) examined the roles of 4 1 and 4 7 in transfer and active models of EAE in mice using monoclonal antibodies to 4 1, 4 7, the 7-chain and VCAM-1 and demonstrated that 4 7 integrin is not essential for the development of EAE.”
BackgroundIVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment
Lapointe, B. M., Herx, L., Gill, V., Metz, L. M., & Kubes, P. (2004) · Brain · doi:10.1093/brain/awh297 · Cited by 58
“Recently, use of a4-integrin antibody revealed benefit in both animal models of multiple sclerosis (Engelhardt et al., 1998) and in patients (Miller et al.”
BackgroundRudolph, H., Klopstein, A., Gruber, I., Blatti, C., Lyck, R., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201546251 · Cited by 52
Self-citationAllavena, R., Noy, S., Andrews, M., & Pullen, N. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090437 · Cited by 53
Sathiyanadan, K., Coisne, C., Enzmann, G., Deutsch, U., & Engelhardt, B. (2014) · European Journal of Immunology · doi:10.1002/eji.201344214 · Cited by 51
Self-citation
Metadata
- Authors
- Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G.
- Affiliations
- Max Planck Society (DE)
- University of Münster (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-12-15
- Volume
- 102
- Issue
- 12
- Pages
- 2096-2105
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC509164
- OpenAlex
- W2155492240
- Cited by
- 203
- References
- 39
- Citations by year
- 2024: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 11
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- experimental autoimmune encephalomyelitis, CD49d, alpha4beta7 integrin, VCAM-1, blood-brain barrier, encephalitogenic T cells, T cell proliferation, autoimmunity, integrin heterodimers
- MeSH terms
- Animals, Antibodies, Monoclonal, Cell Adhesion, Cell Division, Cell Line, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Immunization, Mice, Inbred Strains, Peptide Fragments, Recombinant Proteins, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Cell Adhesion Molecules, Integrins, Myelin Proteolipid Protein, Vascular Cell Adhesion Molecule-1, Integrin alpha4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.